ERNA vs TRV · P/E 0.0, rev $582.0K vs P/E 14, rev $48.83B
Eterna Therapeutics Inc (ERNA) versus The Travelers Companies Inc (TRV) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
The Travelers Companies Inc (TRV) is a insurance - property & casualty company listed on US.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported TRV revenue for 2025-12-31 was $48.83B. Net income was $6.29B. Revenue was up 5.2% from 2024-12-31 to 2025-12-31. TRV currently screens at market cap $59.84B and trailing P/E 14.4.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. TRV currently screens at market cap $59.84B and trailing P/E 14.4.
Not investment advice. Open the ERNA and TRV stock pages for the full models.
Not investment advice.